✦ LIBER ✦

Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer

✍ Scribed by Kirby, A M; A'hern, R P; D'ambrosio, C; Tanay, M; Syrigos, K N; Rogers, S J; Box, C; Eccles, S A; Nutting, C M; Harrington, K J

Book ID: 109998740
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 103 KB
Volume: 94
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6602999

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly paclitaxel in patients with recur

Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer

✍ M. Tahara; H. Minami; Y. Hasegawa; K. Tomita; A. Watanabe; K. Nibu; M. Fujii; Y. 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 240 KB

Phase II study of rubitecan in recurrent

Phase II study of rubitecan in recurrent or metastatic head and neck cancer

✍ Francesco Caponigro; Giacomo Cartenì; Jean Pierre Droz; Amalia Milano; Wayne B. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 236 KB

Phase II study of capecitabine as pallia

Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment

✍ Martinez-Trufero, J; Isla, D; Adansa, J C; Irigoyen, A; Hitt, R; Gil-Arnaiz, I; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 306 KB

Methotrexate alone or with regional subc

Methotrexate alone or with regional subcutaneous corynebacterium parvum in the treatment of recurrent and metastatic squamous cancer of the head and neck

✍ Steven E. Vogl; David A. Schoenfeld; Barry H. Kaplan; Harvey J. Lerner; John Hor 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 564 KB

Phase I/II study of S-1 combined with ca

Phase I/II study of S-1 combined with carboplatin in recurrent and/or metastatic head and neck cancer as outpatient chemotherapy

✍ Akihito Watanabe; Masanobu Taniguchi; Tetsuro Yamashita; Michihiro Ueda; Tatsuya 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## Background. The aims of this study were to determine the recommended dose (RD) in combination chemotherapy of S‐1 and carboplatin in recurrent and/or metastatic head and neck cancer (phase I) and to examine response rate and toxicities at RD (phase II). ## Methods. S‐1 was given o

A phase II study of sunitinib in patient

A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer

✍ George Fountzilas; Anna Fragkoulidi; Anna Kalogera-Fountzila; Martha Nikolaidou; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 639 KB